CapitolRadar tracks every publicly disclosed JNJ trade by US congress members and corporate insiders: 121 disclosed trades (72 buys, 49 sells) by 13 tracked traders, from 2018-12-11 to 2026-09-25. Updated daily from official filings.
🔥 In the news right now: JNJ picked up 43 news headlines in the last 48 hours. Attention is not evidence. It tells you what people are looking at, not whether they are right.
Want a ping when Congress buys JNJ? Free email alerts on notable disclosed trades — plus a $100,000 fantasy portfolio to play along against three AI traders. Join free
Johnson & Johnson (JNJ) — Healthcare · Drug Manufacturers - General, market cap about $618.1B.
Cluster watch: 3 distinct tracked traders disclosed buying JNJ in the last 45 days: Lloyd Alton Doggett, Ro Khanna, Schmid Timothy (officer: EVP, WW Chair, MedTech).
CapitolRadar analysis
90 tracked trades lean toward purchases
JNJ has 90 tracked trades from 2019-12-05 through 2026-07-30, comprising 55 buys and 35 sells by 10 distinct traders. That gives buys a 20-trade lead and places them at roughly three-fifths of the recorded activity. The sample spans several years, but 10 traders remains a small group, so the aggregate should not be read as a broad measure of congressional sentiment toward Johnson & Johnson or the Healthcare / Drug Manufacturers - General industry.
31 recent trades, with buying strongest in late 2024
The eight reported quarters from 2024 Q4 through 2026 Q3 contain 31 trades and 20 buys. The busiest was 2024 Q4, with 9 trades and 7 buys. Activity then moderated: 2025 Q1 recorded 5 trades and 4 buys; Q2 had 4 and 2; Q3 had 2 and 2; and Q4 had 3 and 2. In 2026, Q1 had 4 trades but only 1 buy, while Q2 and Q3 each had 2 trades and 1 buy. Those quarterly samples are small—especially the two-trade quarters—so shifts in the buy/sell mix can reflect only a handful of disclosures.
23 Ro Khanna buys lead the named buyer list
Ro Khanna accounts for 23 buys, most recently on 2026-07-02. Kevin Hern follows with 10 buys, last on 2024-03-05, and Josh Gottheimer has 8, last on 2025-01-24. Marjorie Taylor Greene has 4 buys; Diana Harshbarger has 3; and Rich McCormick, Jared Moskowitz and Lois Frankel each have 2. Together, these named rows account for 54 of the 55 buys.
Overlap with other stocks is limited: three of these buyers also bought MSFT, three bought HD and three bought PANW; two each also bought ADI, FCX and ICE. Disclosures may be filed up to 45 days after a trade, so dates may not represent real-time activity. Dollar amounts were not supplied here; when disclosures use amount ranges, resulting value totals are estimates rather than exact figures.
Analysis written from the tracked record on 2026-09-09; it is refreshed whenever the underlying numbers change.
Activity by quarter
| Quarter | Disclosed trades | Buys | Sells |
|---|---|---|---|
| 2026 Q3 | 8 | 4 | 4 |
| 2026 Q2 | 2 | 1 | 1 |
| 2026 Q1 | 4 | 1 | 3 |
| 2025 Q4 | 3 | 2 | 1 |
| 2025 Q3 | 3 | 3 | 0 |
| 2025 Q2 | 5 | 2 | 3 |
| 2025 Q1 | 5 | 4 | 1 |
| 2024 Q4 | 10 | 7 | 3 |
Who is buying JNJ?
| Trader | Disclosed buys | Last buy | Grade |
|---|---|---|---|
| Ro Khanna | 26 | 2026-09-25 | — |
| Kevin Hern | 20 | 2024-03-05 | — |
| Josh Gottheimer | 8 | 2025-01-24 | — |
| Marjorie Taylor Greene | 4 | 2025-05-05 | — |
| Lois Frankel | 4 | 2023-02-08 | — |
| Jared Moskowitz | 3 | 2024-11-08 | — |
| Diana Harshbarger | 3 | 2022-06-08 | — |
| Rich McCormick | 2 | 2025-11-05 | — |
Disclosed trades in JNJ
| Date | Who | Type | Amount | 30d vs SPY |
|---|---|---|---|---|
| 2026-09-25 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2026-09-08 | Lloyd Alton Doggett | buy | $1,001 - $15,000 | — |
| 2026-09-04 | Ro Khanna | buy | $15,001 - $50,000 | — |
| 2026-08-27 | Thomas H. Kean | sell | $1,001 - $15,000 | — |
| 2026-08-20 | John Boozman | sell | $1,001 - $15,000 | — |
| 2026-08-07 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2026-07-30 | Rich McCormick | sell | $1,001 - $15,000 | — |
| 2026-07-02 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2026-05-01 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2026-04-13 | Ro Khanna | buy | $15,001 - $50,000 | — |
| 2026-03-19 | Rich McCormick | sell | $1,001 - $15,000 | — |
| 2026-03-06 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2026-03-06 | Ro Khanna | sell | $1,001 - $15,000 | — |
| 2026-01-29 | Ro Khanna | sell | $15,001 - $50,000 | — |
| 2025-11-05 | Rich McCormick | buy | $1,001 - $15,000 | — |
| 2025-10-30 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2025-10-10 | Jared Moskowitz | sell | $1,001 - $15,000 | — |
| 2025-09-29 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2025-08-04 | Ro Khanna | buy | $1,001 - $15,000 | — |
| 2025-08-04 | Ro Khanna | buy | $1,000 - $15,000 | — |
CapitolRadar signal history
NEW PICK 2026-10-12
Rep. Ro Khanna disclosed a $1,001–$15,000 purchase of Johnson & Johnson stock. The panel passed mainly because Khanna has no verified trading history against the S&P 500, so this buyer signal is unproven despite two other recent tracked buyers. A documented record of his prior purchases outperforming the market would have been the strongest evidence to change the verdict.
NEW PICK 2026-09-04
Johnson & Johnson executive Timothy Schmid disclosed a roughly $3.41 million purchase of JNJ stock. The panel passed mainly because he has no verified trading history, so the large purchase remains an unproven signal despite its size and prompt disclosure. A documented record showing that his earlier purchases consistently outperformed SPY would have provided the strongest evidence to change the verdict.
These buyers also bought
Other stocks the tracked buyers of JNJ disclosed buying in the last six months: MSFT (3) · AMD (2) · RSG (2) · MNST (2) · ADI (2) · CB (2).
About Johnson & Johnson
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. i…
Frequently asked questions
Which politicians bought JNJ most?
Ro Khanna leads with 26 disclosed buys, followed by Kevin Hern.
How current is this page?
It re-renders from the tracked record on every view and new filings are ingested daily — but STOCK Act disclosures can lag the trade by up to 45 days, so the most recent weeks are always incomplete.
Get alerts when trades like these are disclosed. Free account: fantasy portfolio + email alerts. Premium: a 6-hour head start on every signal.
CapitolRadar tracks publicly disclosed trades (STOCK Act filings and SEC Form 4). Disclosures can lag the trade by up to 45 days. Backtests measure past disclosed buys against the S&P 500 and do not predict future results. Everything on this page is impersonal information for your own research — not investment advice.